FFCP PHASE2:Hg19::chr11:82612763..82612808,+
From FANTOM5_SSTAR
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Short description: | p1@C11orf82 |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_1_at_C11orf82_5end |
Coexpression cluster: | C109_Reticulocytes_non_acute_Hodgkin_Burkitt_retinoblastoma_lymphoma |
Association with transcript: | 0bp_to_ENST00000525388, ENST00000528189, ENST00000532589, ENST00000532764, ENST00000533655_5end |
EntrezGene: | C11orf82 |
HGNC: | 26351 |
UniProt: | B4DS54E9PQP9E9PMA7 |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
Sample | p1@C11orf82 |
---|
0
5
10
15
20
25
30
35
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
cancer | 5.38e-54 | 235 |
disease of cellular proliferation | 2.42e-52 | 239 |
cell type cancer | 1.27e-27 | 143 |
organ system cancer | 1.51e-24 | 137 |
hematologic cancer | 4.06e-22 | 51 |
immune system cancer | 4.06e-22 | 51 |
carcinoma | 4.69e-21 | 106 |
leukemia | 3.58e-18 | 39 |
myeloid leukemia | 7.06e-14 | 31 |
germ cell and embryonal cancer | 9.80e-07 | 22 |
Showing 1 to 10 of 11 entries